Shao F, Lai X, Tong L, Li L, Ye D, Jin L
BMC Gastroenterol. 2023; 23(1):232.
PMID: 37430251
PMC: 10331958.
DOI: 10.1186/s12876-023-02870-9.
Chi F, Zhou S, Bi T, Zhao W, Wang X
Arch Med Sci. 2023; 19(3):633-637.
PMID: 37313205
PMC: 10259405.
DOI: 10.5114/aoms/112531.
Huang M, Ye Y, Chen Y, Zhu J, Xu L, Cheng W
Front Genet. 2022; 13:955240.
PMID: 36246600
PMC: 9561096.
DOI: 10.3389/fgene.2022.955240.
Mohammed A, Arif S, Pity I
Ann Med Surg (Lond). 2020; 57:311-314.
PMID: 32874562
PMC: 7452034.
DOI: 10.1016/j.amsu.2020.08.006.
Surov A, Meyer H, Hohn A, Behrmann C, Wienke A, Spielmann R
Oncotarget. 2017; 8(13):21974-21983.
PMID: 28423540
PMC: 5400638.
DOI: 10.18632/oncotarget.15753.
A phase I and pharmacokinetic study of afilbercept with FOLFIRI: comparison of Chinese and Caucasian populations.
Xu J, Li Y, Sun X, Zhang D, Liu R, Ziti-Ljajic S
Invest New Drugs. 2017; 35(4):463-470.
PMID: 28102464
DOI: 10.1007/s10637-016-0421-0.
Clinicopathological significance of vascular endothelial growth factor, thymidine phosphorylase and microvessel density in colorectal cancer.
Kimura Y, Morohashi S, Yoshizawa T, Suzuki T, Morohashi H, Sakamoto Y
Mol Med Rep. 2015; 13(2):1551-7.
PMID: 26676225
PMC: 4732825.
DOI: 10.3892/mmr.2015.4687.
A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features.
Salazar R, Capdevila J, Laquente B, Luis Manzano J, Pericay C, Villacampa M
BMC Cancer. 2015; 15:60.
PMID: 25886378
PMC: 4343271.
DOI: 10.1186/s12885-015-1053-z.
Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma.
Lee S, Jeung I, Park T, Lee K, Lee D, Cho Y
Oncotarget. 2015; 6(9):7182-94.
PMID: 25762629
PMC: 4466677.
DOI: 10.18632/oncotarget.3121.
Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents.
Garcia-Alfonso P, Ferrer A, Gil S, Duenas R, Perez M, Molina R
Target Oncol. 2015; 10(4):453-65.
PMID: 25752908
PMC: 4668275.
DOI: 10.1007/s11523-015-0362-0.
Can vascular endothelial growth factor and microvessel density be used as prognostic biomarkers for colorectal cancer? A systematic review and meta-analysis.
Wang Y, Yao X, Ge J, Hu F, Zhao Y
ScientificWorldJournal. 2014; 2014:102736.
PMID: 25143961
PMC: 3985294.
DOI: 10.1155/2014/102736.
Effect of M1a and M1b category in metastatic colorectal cancer.
Kennecke H, Yu J, Gill S, Cheung W, Blanke C, Speers C
Oncologist. 2014; 19(7):720-6.
PMID: 24899642
PMC: 4077443.
DOI: 10.1634/theoncologist.2013-0442.
Prognostic biomarkers in colorectal cancer: where do we stand?.
Sagaert X
Virchows Arch. 2014; 464(3):379-91.
PMID: 24487787
DOI: 10.1007/s00428-013-1532-z.
Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.
Kline C, El-Deiry W
Pharmaceuticals (Basel). 2013; 6(8):988-1038.
PMID: 24276379
PMC: 3817731.
DOI: 10.3390/ph6080988.
Visualising and quantifying angiogenesis in metastatic colorectal cancer : A comparison of methods and their predictive value for chemotherapy response.
Hansen T, Nielsen B, Jakobsen A, Sorensen F
Cell Oncol (Dordr). 2013; 36(4):341-50.
PMID: 23838926
DOI: 10.1007/s13402-013-0139-3.
Flt-1 in colorectal cancer cells is required for the tumor invasive effect of placental growth factor through a p38-MMP9 pathway.
Wei S, Tsao P, Weng M, Cao Z, Wong J
J Biomed Sci. 2013; 20:39.
PMID: 23799978
PMC: 3704813.
DOI: 10.1186/1423-0127-20-39.
Correlations of dynamic contrast-enhanced magnetic resonance imaging with morphologic, angiogenic, and molecular prognostic factors in rectal cancer.
Hong H, Kim S, Park H, Park M, Kim K, Kim W
Yonsei Med J. 2012; 54(1):123-30.
PMID: 23225808
PMC: 3521250.
DOI: 10.3349/ymj.2013.54.1.123.
Gene expression analysis in human breast cancer associated blood vessels.
Jones D, Lechertier T, Mitter R, Herbert J, Bicknell R, Jones J
PLoS One. 2012; 7(10):e44294.
PMID: 23056178
PMC: 3462779.
DOI: 10.1371/journal.pone.0044294.
Perfusion CT in colorectal cancer: comparison of perfusion parameters with tumor grade and microvessel density.
Kim J, Jeong Y, Chang N, Heo S, Shin S, Lee J
Korean J Radiol. 2012; 13 Suppl 1:S89-97.
PMID: 22563293
PMC: 3341466.
DOI: 10.3348/kjr.2012.13.S1.S89.
The histological growth pattern of colorectal cancer liver metastases has prognostic value.
Van den Eynden G, Bird N, Majeed A, Van Laere S, Dirix L, Vermeulen P
Clin Exp Metastasis. 2012; 29(6):541-9.
PMID: 22476470
DOI: 10.1007/s10585-012-9469-1.